In the area of molecular biology, we offer real-time PCR technology platforms that integrate extraction, amplification and detection steps in a single cartridge to determine gene mutations, pathogens that cause sepsis and respiratory tract diseases.
We also offer molecular diagnostic technologies based on multiplex PCR and macroarray chip for detection of HPV (Human Papillomavirus), sexually transmitted diseases, sepsis and antimicrobial resistance genes, detection of viruses and disease-causing bacteria in the central nervous system, among others.
In addition, we offer innovative new generation sequencing platforms (NGS) through the quality of data obtained from the use of kits, reagents, and software analysis in the area of research for microbiology, cancer, cell and molecular biology, genomics of complex diseases and agrogenomics.
Brands Represented
Biocartis is a molecular diagnostic company, whose products are intended to improve clinical practice, focusing on benefiting the patient in oncological and clinical laboratory areas. With its unique and exclusive platform IdyllaTM, fully automated (from sample to result), Biocartis has developed tests for mutations detection in patients with melanoma, colorectal and lung cancer, as well as tests for the detection of respiratory pathogens, including SARS CoV-2 and sepsis.
GenMark Diagnostics is a company that offers solutions for the molecular diagnosis of multiple pathogens in samples of patients with suspected sepsis and viral and bacterial diseases that affect the respiratory tract, including SARS CoV-2. Its fully automated single cartridge tests are processed on ePlex instruments and are based on the use of eSensor technology combined with digital microfluidics. In this way, the workflow in the clinical laboratory is optimized and delivery times of results to patients are reduced.
The company Vitro S.A. has experience in the development, production and commercialization of instruments and reagents for immunohistochemistry and molecular diagnosis. With a focus on biotechnology, it offers clinical and pathology laboratories solutions for the in vitro diagnosis of oncological and infectious diseases (sexually transmitted diseases, tick-borne diseases, among others) as well as the detection of antibiotic resistant genes from samples of histological, cytological, and biological origin.
Illumina is a leading developer, manufacturer, and marketer of life science tools and embedded systems for large-scale analysis of genetic variation and function. Illumina provides next generation sequencing equipment and reagents that are not only innovative but also flexible and scalable, with industry leading support and service.
It is a leading company in the field of molecular diagnostics, founded in 2003, offering products in the field of clinical diagnostics, focusing on the distribution and manufacture of reagents and kits, which guarantee the highest quality standards, covering various fields of diagnostics: molecular biology, microbiology and next generation sequencing (NGS).